EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme

David Akhavan iD, Siddharth Subham iD, John D Jeppson, Brenda Aguilar, Robyn A Wong, Jonathan C Hibbard, Susanta Hui, Jeffrey Y C Wong, Stephen J Forman, Darya Alizadeh, Christine E Brown

Cells · 2024

DOI: 10.3390/cells13131075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von David Akhavan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA. Hauptthemen laut MEDLINE: Glioblastoma, Receptors, Chimeric Antigen, Tumor Microenvironment. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Curings Kids Cancer Foundation, Curing Kids Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Standard-of-care treatment for Glioblastoma Multiforme (GBM) is comprised of surgery and adjuvant chemoradiation. Chimeric Antigen Receptor (CAR) T cell therapy has demonstrated disease-modifying activity in GBM and holds great promise. Radiation, a standard-of-care treatment for GBM, has well-known immunomodulatory properties and may overcome the immunosuppressive tumor microenvironment (TME); however, radiation dose optimization and integration with CAR T cell therapy is not well defined. Murine immunocompetent models of GBM were treated with titrated doses of stereotactic radiosurgery (SRS) of 5, 10, and 20 Gray (Gy), and the TME was analyzed using Nanostring. A conditioning dose of 10 Gy was determined based on tumor growth kinetics and gene expression changes in the TME. We demonstrate that a conditioning dose of 10 Gy activates innate and adaptive immune cells in the TME. Mice treated with 10 Gy in combination with mCAR T cells demonstrated enhanced antitumor activity and superior memory responses to rechallenge with IL13Rα2-positive tumors. Furthermore, 10 Gy plus mCAR T cells also protected against IL13Rα2-negative tumors through a mechanism that was, in part, c-GAS-STING pathway-dependent. Together, these findings support combination conditioning with low-dose 10 Gy radiation in combination with mCAR T cells as a therapeutic strategy for GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaReceptors, Chimeric AntigenTumor MicroenvironmentAnimalsMiceHumansCell Line, TumorImmunotherapy, AdoptiveBrain NeoplasmsT-LymphocytesMice, Inbred C57BLImmunomodulationFemale

Stichwörter der Autor:innen

CAR T cell therapyIL13Rα2c-GAS-STING pathwayglioblastomaradiationtumor microenvironment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Kansas Cancer Center, Kansas City, KS 66160, USA.
  • Department of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS 66160, USA.
  • Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, KS 66160, USA.
  • Bioengineering Program, University of Kansas, Lawrence, KS 66045, USA.
  • Department of Immuno-Oncology, City of Hope Beckman Research Institute, Duarte, CA 91010, USA.
  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA 91010, USA.

ORCID-Profile: David Akhavan, Siddharth Subham

Förderung

  • Curings Kids Cancer Foundation
  • Curing Kids Cancer Foundation

Zitieren

APA

Akhavan, D., Subham, S., Jeppson, J. D., Aguilar, B., Wong, R. A., Hibbard, J. C., Hui, S., Wong, J. Y. C., Forman, S. J., Alizadeh, D., & Brown, C. E. (2024). Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme. Cells. https://doi.org/10.3390/cells13131075

Vancouver

Akhavan D, Subham S, Jeppson JD, Aguilar B, Wong RA, Hibbard JC, et al. Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme. Cells. 2024. doi:10.3390/cells13131075

BibTeX
@article{Akhavan2024,
  author = {Akhavan, David and Subham, Siddharth and Jeppson, John D and Aguilar, Brenda and Wong, Robyn A and Hibbard, Jonathan C and Hui, Susanta and Wong, Jeffrey Y C and Forman, Stephen J and Alizadeh, Darya and Brown, Christine E},
  title = {Evaluation of the Immunomodulatory Effects of Radiation for Chimeric Antigen Receptor T Cell Therapy in Glioblastoma Multiforme},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13131075}
}
Kostenlos starten →